For example, the use of the 22C3 diagnostic platform with a CPS cutoff of 2% demonstrated that the ORR was marginally greater in PD-L1-positive tumor cases (18%) than in PD-L1-negative tumor cases (12%). This evidence concerns the gene CD274 and neoplasm.